Merck ‘good cholesterol’ drug study wows doctors » AHA-Web

Dr. Christopher Cannon, the leader of a study on an experimental Merck cholesterol drug, speaks at an American Heart Association conference in Chicago Wednesday. (AP Photo/American Heart Association)

Dr. Christopher Cannon, the leader of a study on an experimental Merck cholesterol drug, speaks at an American Heart Association conference in Chicago Wednesday. (AP Photo/American Heart Association)


This entry was posted on Wednesday, November 17th, 2010 at 4:07 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.

Comments are closed.